Medline ® Abstract for Reference 28
of 'High resolution computed tomography of the lungs'
Noninfectious pulmonary complications after hematopoietic stem cell transplantation: practical approach to imaging diagnosis.
Peña E, Souza CA, Escuissato DL, Gomes MM, Allan D, Tay J, Dennie CJ
Radiographics. 2014 May-Jun;34(3):663-83.
Hematopoietic stem cell transplantation (HSCT) is a widely available treatment for a variety of malignant and nonmalignant disorders. The treatment outcome is affected by the type of transplant and is limited by complications secondary to immunosuppression and treatment-related toxicity. Pulmonary complications are very common and follow a predictable timeline that reflects the immunologic status of the patient in the peritransplant period. Until recently, pulmonary complications were largely attributed to infectious causes. However, advances in diagnosis and treatment have led to a shift, and noninfectious complications have emerged as a major cause of morbidity and mortality in this population. With the increasing number of centers that perform HSCT, knowledge of posttransplant noninfectious pulmonary complications has become increasingly relevant. The basic principles of and indications for HSCT are described, and a timeline for the clinical, radiologic, and pathologic manifestations of noninfectiouspulmonary complications is presented. Emphasis is given to high-resolution computed tomographic findings and the role of imaging in management of complications. A practical approach is provided to guide imaging interpretation and diagnosis of noninfectious pulmonary complications after HSCT.
From the Department of Medical Imaging, Division of Cardiothoracic Radiology (E.P., C.A.S., C.J.D.), Department of Pathology and Laboratory Medicine (M.M.G.), and Blood and Marrow Transplant Program, Department of Medicine (D.A., J.T.), Ottawa Hospital, University of Ottawa, General Campus, 501 Smyth Rd, Ottawa, ON K1H 8L6, Canada; and Department of Internal Medicine, Federal University of Paraná, Curitiba, Brazil (D.L.E.).